In accordance, p53 was shown to be mostly cytoplasmic in CML CD34 positive cells, with a further cytoplasmic accumulation upon imatinib and treatment with DNA-damaging agents [46]. The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.